Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Dallas TX, San Antonio TX, Missouri City TX,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07783542

Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Dallas TX, Houston TX, Baton Rouge LA, Overland Park KS,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

for
Geographic Atrophy
Location: Southlake TX, Dallas TX, Arlington TX, Austin TX,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07215234

Phase 1, Phase 2, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Dallas TX, Longview TX, Bellaire TX, Houston TX,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase 2, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Dallas TX, Denison TX, Houston TX, San Antonio TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Houston TX, Aurora CO, Atlanta GA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659782

Phase 2, Recruiting

Venous Compression in Fontan

for
Single-ventricle, Fontan Circulation
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 45

Code: NCT07220226

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Dallas TX, Austin TX, San Antonio TX, Little Rock AR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Dallas TX, Bellaire TX, Leawood KS, St Louis MO,
Sponsor: Incyte Corporation

Sex: All

Age: 12 - 17

Code: NCT07213973

Phase 2, Recruiting

Palatal Volumetric Change Analysis Following Connective Tissue Graft With and Without Donor Site Augmentation

for
Recession, Gingival
Location: Dallas TX
Sponsor: Hailey Bivens

Sex: All

Age: 18 - 65

Code: NCT05961566

Recruiting

The Omeza Protocol for Chronic Ulcers

for
Venous Leg Ulcer, Diabetic Foot Ulcer
Location: Dallas TX, Jacksonville FL, Newark NJ, Portland OR
Sponsor: Omeza, LLC

Sex: All

Age: 21 - 70+

Code: NCT04198441

Recruiting

Improving Sleep Quality During Pregnancy Using an Oral Appliance

for
Snoring, Sleep Fragmentation
Location: Dallas TX
Sponsor: Texas A&M University

Sex: Female

Age: 18 - 45

Code: NCT03646214

Recruiting

The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain® MI Compared to Traditional SRCP

for
Periodontitis, Attachment Loss, Periodontal
Location: Dallas TX
Sponsor: Texas A&M University

Sex: All

Age: 30 - 70+

Code: NCT05964699

Recruiting
New

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Fort Worth TX, Orlando FL, Fountain Valley CA
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07743164

Phase 3, Recruiting

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

for
Cardiac Failure, Graft Rejection
Location: Dallas TX, Nashville TN, Charleston SC, Los Angeles CA,
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT06939751

Recruiting

Enhancing Heart Allograft Function With the OCS Heart System Trial

for
Heart Transplant
Location: Dallas TX, Tampa FL, Durham NC, New York NY,
Sponsor: TransMedics

Sex: All

Age: 18+

Code: NCT07145515

Recruiting

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

for
Heart Failure
Location: Dallas TX, Los Angeles CA
Sponsor: Baylor Research Institute

Sex: All

Age: 18 - 70+

Code: NCT03383419

Phase 2, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Southlake TX, Mesquite TX, Tyler TX, Mandeville LA,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184944

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Southlake TX, Dallas TX, Mesquite NV, Tyler TX,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase 3, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Southlake TX, Mandeville LA, Tyler TX, Kingwood TX,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07185009

Phase 3, Recruiting